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Abstract: The phenolic compound phloridzin (phloretin 2′-O-glucoside, variously named 
phlorizin, phlorrhizin, phlorhizin or phlorizoside) is a prominent member of the chemical 
class of dihydrochalcones, which are phenylpropanoids. Phloridzin is specifically found in 
apple and apple juice and known for its biological properties. In particular we were 
attracted by potential dermo-cosmetic applications. Here we report the synthesis, stability 
studies and antimicrobial activity of compound F2, a new semi-synthetic derivative of 
phloridzin. The new derivative was also included in finished formulations to evaluate its 
stability with a view to a potential topical use. Stability studies were performed by HPLC; 
PCL assay and ORAC tests were used to determine the antioxidant activity. F2 presented 
an antioxidant activity very close to that of the parent phloridzin, but, unlike the latter, was 
more stable in formulations. To further explore potential health claims, antifungal activity 
of phloridzin and its derivative F2 were determined; the results, however, were rather low; 
the highest value was 31,6% of inhibition reached by F2 on Microsporum canis at the 
highest dose. 
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1. Introduction 
Phloridzin (phloretin 2′-glucoside, phlorhizin, phlorrhizin) belongs to the chemical class of 
dihydrochalcones, phenylpropanoids with structures closely related to those of the immediate 
flavonoid precursors, the chalcones, and it is the major phenolic glucoside found in apple trees. 
Phloridzin has a bitter taste that contributes to the characteristic tang of cider [1], moreover the color of 
the apple juices derives from its dimerized oxidation products [2]. However, since its first isolation 
from the bark of apple trees in 1835 by De Koninck [3], phlorizin has attracted most scientific interest 
as a pharmaceutical and as a tool for human physiology research.  
Since year 2000 more than 700 peer reviewed articles, dealing with phloridzin or its derivatives, 
have appeared in literature. Its principal pharmacological action is to produce renal glycosuria and 
block intestinal glucose adsorption by inhibition of the sodium-linked glucose transporters. Most 
studies about phloridzin and its derivatives relate to antioxidant activity in vitro, with a wide range of 
biological related functions, such as inhibition of lipid peroxidation, prevention of bone loss, 
enhancement of memory and life extension as well as inhibition of cancer cell growth [4–14]. 
In contrast, knowledge about the physiological relevance of phloridzin in plants is limited. The 
biosynthetic steps leading to phloridzin were recently investigated with recombinant enzymes [15,16] 
and plant protein extracts [17]. 
Phloridzin not only exists in Malus species, in fact, phloretin glycosides have been founded in the 
leaves of Australian native sarsaparilla (Smilax glyciphylla) [18], sweet tea (Lithocarpus polystachyus) [19] 
and at very low levels in strawberry fruit [20]. In apple trees, phloridzin is found primarily in the 
young shoots, roots, leaves and bark, while in fruit, it is most abundant in the seeds, with intermediate 
levels in both the core and the skin, and the lowest level in the cortex. Despite this information, little is 
known of the phloridzin roles in plants (i.e., apple tree physiology) although it has been suggested that 
it might act in apple tree growth and development [21] or as an inhibitor of bacterial [22] or fungal 
parasite growth [23]. 
It is well known that a diet high in fruits and vegetables decreases the risk of chronic diseases [24–27]. 
Most of the protective effects of fruits and vegetables have been assigned to phytochemicals,  
such as carotenoids, phenolics, flavonoids, and isoflavonoids which have different activities [28–31]. 
Phenylpropanoids are very interesting components among phenolics, but their dermo-cosmetic 
applications are very scarcely described in literature, we were thus attracted by the claimed  
photo-genoprotective effect of phloridzin-rich polyphenolic fractions [32]. The free-radical-scavenging 
mediated, anti-ultraviolet protective role of a phloridzin-rich polyphenolic fractions was measured on 
plasmid DNA. [33]. These effects, based on the antioxidant activity, are very interesting to the  
dermo-cosmetic field in view of the increasing attention of dermatologists to the solar DNA induced 
damages. In this application, the protective role was assessed against ultraviolet B rays in comparison 
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to Parsol® MCX (2-methylhexyl p-methoxycinnamate). With an IC50 slightly less than Parsol® MCX, 
the polyphenolic extracts nevertheless showed large anti-ultraviolet B activity.  
Moreover, polyphenols-like structures also offer interesting dermo-cosmetic applications as 
potential antifungal agents, and this aspect has been also investigated in extracts from Mallus species [34]. 
Due to this latter information we also focused our attention on the antifungal activities of phloridzin. 
However, during preliminary investigations, in the aim to design topical formulations, important 
drawbacks were encountered in terms of very poor stability of phloridzin in finished formulations. The 
aglycon is much more easy to handle but it is not the natural form in which it is found in plants. In line 
with our recent strategy applied on other natural phenylpropanoids derivatives [35] we investigated 
novel phoridzin semi-synthetic derivatives in order to devise possible pro-drug forms. The latter  
were also investigated for stability in solutions at different pH and storage conditions and in finished  
dermo-cosmetic formulations. The antioxidant activity of the synthetic derivative F2 and of the 
finished formulae containing it was determined by ORAC test and PCL assay, whereas antifungal 
activity was evaluated on nine dermatophytes in comparison between phloridzin and F2. The leading 
concept was that derivatization will increase the range of applications. 
2. Results and Discussion 
2.1. Chemistry 
Phloridzin was esterified at all hydroxyl moieties using an acyl chloride in presence of  
4-dimethylaminopyridine (4-DMAP) and then selectively deprotonated at the phenolic hydroxyl 
groups, using N,N,N-triethylamine (TEA) in methanol (Scheme 1). 
Scheme 1. Synthesis of the tetra-substituted derivative of phloridzin F2. 
 
Reagents: i: DMAP, Propionyl Chloride, CH2Cl2, ii: TEA, MeOH. 
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2.2. Stability Studies 
With the aim to evaluate the behaviour of phloridzin and F2 as a function of time, pH and storage 
conditions, we conducted a stability study. Phloridzin was analyzed in MeOH, EtOH, EtOH–H2O 
solution (80:20, v/v) and in phosphate buffer solutions at pH 7, 6 and 5. All the solutions were stored 
at room temperature kept in the dark and subjected to accelerated aging at 40 °C in an oven. We have 
observed that phloridzin slowly precipitates at room temperature from the buffered solution at pH 5 
over two weeks, whereas after 60 days in the oven, where solubility is complete, the recovery 
percentage is about 85.7%. This fact made it impossible to follow the stability at room temperature. 
The same behaviour was observed at pH 6. In all the other solutions, phloridzin was soluble and 
resulted stable with not too pronounced differences between room temperature and oven samples. We 
observed the best recoveries percentages of phloridzin over time (94%) in the sample in EtOH kept in 
the dark (Figure 1). 
Figure 1. Phloridzin stability in solution at different pH values and storage conditions. 
 
Regarding F2, we have evaluated MeOH, EtOH and EtOH-H2O solutions (80:20, v/v) as well. F2 
was not soluble at all in the buffer solutions used for the parent phlorizin study. Regarding the MeOH 
solutions, the results show that F2 completely disappears after 6 weeks of accelerated aging 
conditions, with concomitant formation of phloridzin, while at room temperature and kept in the dark 
it was quite stable. In EtOH-H2O solution, after 120 days in the oven, F2 hydrolyzed by 50%. In all the 
other solutions F2 is stable (Figure 2). 
In order to measure the lipophilic properties of the molecules, the partition coefficient (LogP), 
calculated as the logarithm of the ratio of concentrations of the substance in octanol and water, was 
evaluated. This determination was conducted in a biphasic system of octanol (20 mL) and water (20 mL 
at pH 6) at 25 °C. After 30 min of stirring, the biphasic mixture was centrifuged for 10 min at 4,000 rpm 
to complete separation of phases and then 5 mL of each phase was used for spectrophotometric 
determination (at 284 nm) concentrations of phloridzin (5 mg/20 mL) at the equilibrium. 
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Figure 2. F2 stability in different solutions under different storage conditions. 
 
A similar analysis has been performed for F2 (5 mg/20 mL). The data (Table 1) shows a higher 
distribution in octanol than in water of phloridzin and F2 (0.94 and 1.82 LogP respectively). These 
data confirm the greater lipophilicity of F2 with respect to its parent compound phloridzin. 
Table 1. Partition coefficients of phloridzin and F2 in a biphasic mixture of octanol and water. 
 Octanol (mg/20 mL) H2O (mg/20 mL) LogP * 
Phloridzin 4.48 0.52 0.94 
F2 4.925 0.075 1.82 
* LogP = log10 [mg/20 mL]octanol/[mg/20 mL]H2O. 
2.3. Antioxidant Activity 
The two compounds were then tested to determine their antioxidant capacity by PCL analysis and 
ORAC test. PCL data showed similar antioxidant activity of the semi-synthetic derivative F2 compared 
to that of phloridzin (0.23 and 0.15 mmol Trolox/mmol of product respectively) (Figure 3, Panel A).  
Figure 3. Panel A: PCL analysis of phloridzin and F2. Panel B: PCL analysis of phloridzin 
and F2 formulations. Each value was obtained from three experiments (Mean ± SE). 
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Figure 3. Cont. 
 
Furthermore, the ORAC test results show a high antioxidant activity with respect to the peroxyl 
radical, with the best results seen for phloridzin as compared to F2 (8.78 and 4.27 µmol Trolox/mmol 
product respectively) probably due to the fact that, being more lipophilic, within 24 h of analysis it 
might precipitate in the PBS (Figure 4). 
Figure 4. ORAC analysis of phloridzin and F2. Each value was obtained from three 
experiments (Mean ± SE).  
 
2.4. Formulation Studies 
Because the high potency of a molecule is useless if not expressed also within a formulation, we 
also investigated the antioxidant activity [36] and the stability of the active components incorporated 
into finished dermo-cosmetic formulations at 0.3% (p/p) and subjected to accelerated aging at 40 °C. 
Two different cosmetic formulations, Formulation 1 (a cosmetic base O/W formula made with 
ingredients devoid of any antioxidant properties) and Formulation 2 (a water free formula also devoid 
of antioxidant properties) were designed. 
PCL analysis (at time zero) has confirmed the antioxidant activity of the formulations containing 
phloridzin and F2 as compared to the cosmetic base (0.81, 0.39 and 0 nanomol Trolox/mg formulation 
respectively) (Figure 3, Panel B). 
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The formulations were subjected to accelerated aging at 40 °C to monitor any changes in the 
products. This study (data not shown) showed that formulations containing phloridzin rapidly turned 
brown and casued separation in the O/W emulsion. Because this variation is not acceptable, we 
decided to focus our attention exclusively on the formulations containing F2. 
PCL analysis of the formulation 1 containing F2, after 150 days at 40 °C, did not show any changes 
in the anti-oxidant activity. Formulations 1 and 2 containing F2, were also evaluated in parallel by 
HPLC to assess the stability in function of time. The analysis showed that F2 is stable in both the 
formulations 1 and 2 (Figure 5). 
Figure 5. F2 recovery in the different formulations stored at 40 °C. Each value was 
obtained from three experiments (Mean ± SE).  
 
2.5. Antufungal Acitivity 
Phloridzin and its derivative F2 have been studied for their antifungal activities against nine  
fungal species [Epidermophyton floccosum(Hartz) Langeron e Milochevitch, Trichophyton rubrum 
(Castellani) Saboraud, Trichophyton tonsurans Malmsten, Trichophyton violaceum, Trichophyton 
mentagrophytes (Robin) Blanchard, Microsporum gypseum (Bodin) Guiart e Grigorakis, Nannizzia 
cajetani Ajello, Microsporum canis Bodin, Nannizzia gypsea (Nann.) Stockd. (perfect state of 
Microsporum gypseum)] using the Sabouraud Dextrose Agar (SDA) diffusion method, in DMSO 
solvent (Table 2). 
As shown in Table 2, the antifungal activity of phloridzin and its derivative F2, did not give 
interesting outcomes: in fact, in all cases the percentages of inhibition are rather low and the highest 
value was 31.63% reached by F2 on Microsporum canis at the highest dose. In other cases the 
substance showed an hormone-like effect with a fungal growth higher than that of the controls (+). 
This occurrence is so far unexplained and awaits future investigations about the possible mechanism of 
action: F2 is mostly a pro-drug of phloridzin and should behave with the same mechanism. 
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Table 2. Growth inhibition following treatment with the two pure standards phloridzin and 
its derivative F2. 
Fungus 
% Growth inhibition on the 7th 
days by phloridzin conc. (g/mL) of 
% Growth inhibition on the 7th 
days by F2 conc. (g/mL) of 
20 100 20 100 
Epidermophyton floccosum + + + + 
Trichophyton rubrum + + 4.1 ± 0.3 4.0 ± 0.7 
Trichophyton tonsurans  13.1 ± 1.1 7.1 ± 0.9 3.1 ± 0.4 8.0 ± 1.5 
Trichophyton violaceum 0.7 ± 0.1 5.1 ± 1.2 20.1 ± 1.8 18.1 ± 1.7 
Trichophyton mentagrophytes + + 22 ± 0.9 18.1 ± 0.7 
Microsporum gypseum 4.1 ± 0.5 + 13.0 ± 1.2 16.0 ± 0.3 
Nannizzia cajetani + + 9.1 ± 0.5 16.0 ± 1 
Microsporum canis + 7 ± 0.8 24.0 ± 1.1 31.6 ± 1.4 
Nannizzia gypsea 0 + 11.0 ± 0.6 20.1 ± 0.8 
3. Experimental 
3.1. General 
All reactives were from Sigma-Aldrch srl (Milan, Italy). Reaction course was routinely monitored 
by thin-layer chromatography on silica gel using precoated Macherey-Nagel Durasil-25 plates with 
detection under a 254-nm UV lamp and/or by spraying the plates with FeCl3 solution or potassium 
permanganate diluted solution. Column chromatography was performed with Macherey-Nagel  
0.063–0.2 mm/70–230 mesh silica gel. The molecular weights of the compounds were determined by 
ESI (Micromass ZMD 2000), and the values are expressed as [MH]+. 1H-NMR spectroscopy was 
obtained using a Bruker AC-200, a Varian VXR-200 or a Mercury Plus400 spectrometer. HPLC 
analysis was performed using an Agilent 1100 Series HPLC System equipped with a G1315A DAD 
and with a Hydro RP18 Sinergi 80A column (4.6 × 150 mm, 4 μm) from Phenomenex. Phloridzin was 
purchased from Sigma Aldrich (Steinheim, Germany). 
3.2. Synthesis 
3.2.1. Synthesis of phlorizin heptaproprionate (F1) 
To a pre-cooled (0 °C) solution of phloridzin (400 mg, 0.92 mmol) and DMAP (4 g, 32.78 mmol)  
in CH2Cl2 (50 mL), propionyl chloride (19.32 mmol) was slowly added. After stirring at room 
temperature for 14 h the reaction mixture was washed with H2O, saturated NaHCO3 and with brine. 
The organic phase was then dried (Na2SO4), filtered and the solvent evaporated under reduced pressure 
to obtain an amber-colored oil. The residue was dissolved in Et2O and washed several times with 
water. The organic phase was then dried (Na2SO4), filtered and the solvent evaporated under reduced 
pressure to obtain a yellow oil. Crystallization with Et2O and petroleum ether, afforded F1 (75% yield) 
as a white powder. 1H-NMR (400 MHz, CDCl3): δ (ppm) 1.163 (m, 21H, 7 × CH3); 2.417 (m, 14H,  
7 × CH2); 2.913 (t, 2H, Ar-CH2-CH2-CO, J = 14.8 Hz); 2.989 (m, 1H, Ar-CH2-CH2-CO); 3.143 (m, 
1H, Ar-CH2-CH2-CO); 3.90 (m, 1H sugar); 4.229 (m, 2H, -OCH2-aglycone); 5.022 (m, 1H sugar); 
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5.149 (m, 1H sugar); 5.276 (m, 1H sugar); 5.297 (m, 1H sugar); 6.684 (d, 1H aromatic, J = 2.2 Hz); 
6.778 (d, 1H aromatic, J = 2.2 Hz); 6.987(d, 2H aromatic, J = 8.8 Hz); 7.247 (d, 2H aromatic,  
J = 8.4 Hz). ESI MS: m/z 829.7 Da [M+H]+, C42H52O17 Mol. Wt. 828,85. 
3.2.2. Synthesis of phlorizin tetraproprionate (F2) 
Et3N (3.5 mL) was added to a solution of F1 (501.8 mg, 0.61 mmol) in anhydrous MeOH (10.4 mL). 
The mixture was stirred at room temperature under argon atmosphere for 17 h and then neutralized by 
adding of formic acid (3 mL) at 0 °C. Next the mixture was evaporated under reduced pressure. The 
crude residue was dissolved in AcOEt and washed with water and brine. The organic phase was than 
dried (Na2SO4), filtered and the solvent evaporated under reduced pressure. The residue obtained was 
purified by silica gel column chromatography (eluent: CH2Cl2/MeOH, 98/2, v/v), gave F2 (51%) as 
ivory foam. 1H-NMR (400 MHz, DMSO-d6): δ (ppm) 0.99 (m, 12H, 4xCH3); 2.22 (m, 8H, 4 × CH2); 
2.699 (t, 2H, Ar-CH2-CH2-CO, J = 7.2 Hz); 2.924 (m, 1H, Ar-CH2-CH2-CO); 3.139 (m, 1H, Ar-CH2-
CH2-CO); 4.046 (m, 1H sugar); 4.254 (m, 2H, -OCH2-aglycone); 5.02 (m, 1H sugar); 5.112 (m, 1H 
sugar); 5.453 (t, 1H sugar, J = 9.6 Hz); 5.693 (d, 1H sugar, J = 8 Hz); 5.984 (d, 1H aromatic, J = 2.2 Hz); 
6.088 (d, 1H aromatic, J = 2.2 Hz); 6.621 (d, 2H aromatic, J = 8.8 Hz); 6.964 (d, 2H aromatic,  
J = 8.4 Hz); 9.11 (s, 1H, OH); 10.58 (s, broad, 1H, OH); 12.76 ( s, 1H, OH). ESI MS: m/z 661.5 Da 
[M+H]+, C33H40O14 Mol. Wt. 660,66. 
3.3. Antioxidant Activity Assays 
3.3.1. Photochemiluminescence (PCL) Method 
The PCL assay, based on the methodology of Popov and Lewin [37], was used to measure the 
antioxidant activity of extracts with a Photochem® apparatus (Analytik Jena, Leipzig, Germany) 
against superoxide anion radicals generated from luminol, a photo-sensitizer, when exposed to UV 
light (Double Bore® phosphor lamp, output 351 nm, 3 mWatt/cm2). The antioxidant activity was 
measured using both Antioxidant Capacity of Water (ACW) soluble substance and Antioxidant 
Capacity of Liposoluble (ACL) substance kits provided by the manufacturer designed to measure the 
antioxidant activity of hydrophilic and lipophilic compounds, respectively [38]. For ACW studies, the 
luminol reagent and Trolox work solution were freshly prepared according to the ACW protocol. The 
presence of Trolox (or any other antioxidants from the extracts) retarded luminescence for a period: 
hence, a lag time was noted before a signal was measured. The duration of the lag, which is calculated 
by the computer software from the first derivative of the detector signal at its turning point and 
intersection with the x-axis, was plotted against the concentration of Trolox added to the assay 
medium. The concentration of the added extract solution was such that the generated luminescence fell 
within the limits of the standard curve. Therefore, the lag time (seconds) for the ACW assay was used 
as the radical scavenging activity and the antioxidant capacity calculated by comparison with a Trolox 
standard curve and then expressed as Trolox equivalent. In ACL studies, the kinetic light emission 
curve, which exhibits no lag phase, was monitored for 180 s and expressed as micromoles of Trolox 
per gram of dry matter. The areas under the curves were calculated using the PCLsoft control and 
analysis software. As greater concentrations of Trolox working solutions were added to the assay 
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medium, a marked reduction in the magnitude of the PCL signal and hence the area calculated from 
the integral was observed. This inhibition was used as a parameter for quantification and related to the 
decrease in the integral of PCL intensities caused by varying concentrations of Trolox. The observed 
inhibition of the signal was plotted against the concentration of Trolox added to the assay medium. 
The concentration of the added extract solution was such that the generated luminescence during the 
180 s sampling interval fell within the limits of the standard curve. The extracts for ACW and ACL 
measurements were centrifuged (5 min at 16,000 g) prior to analysis. The antioxidant assay was 
carried out in triplicate for each sample, and 20 μL of the diluted extract (1:40, v/v) in HPLC-grade 
water (ACW) or HPLC-grade methanol (ACL) was sufficient to correspond to the standard curve.  
3.3.2. Oxygen Radical Absorbance Capacity (ORAC) Assay 
The ORAC assay was carried out on a Fluoroskan FL® ascent (Thermo Fisher Scientific, Inc. 
Waltham, MA, USA) with fluorescent filters (excitation wavelength: 485 nm; emission filter: 538 nm). 
The procedure was based on that given by Hong, Guohua & Ronald as modified in our previous work [39]. 
Briefly, in the final assay mixture (0.2 mL total volume), fluorescein sodium salt (85 nM) was used as 
a target of free radical attack with 2,2′-azobis(2-amidinopropane) dihydrochloride (AAPH) as a 
peroxyl radical generator. Trolox, a water-soluble analogue of vitamin E, was used as a standard 
control: a calibration curve was carried out with 10, 20, 30, 40, 50 μM solution. The tested compounds 
were dissolved in PBS and prepared immediately before the experiments. The fluorescence 
measurements, carried out at 37 °C, were recorded at 5 min intervals up 30 min after the addition of 
AAPH. The ORAC values, calculated as difference of the areas under the quenching curves of 
fluoresceine between the blank and the sample, were expressed as Trolox equivalents (TE), pH = 7.4. 
All the experiments were performed with three replicates. 
3.4. Stability Studies 
3.4.1. Solution Preparation 
The samples were prepared using phlorizin and F2 in different aqueous solution. Phlorizin was 
solubilized in MeOH, EtOH, EtOH/H2O (80:20) and in buffer phosphate solutions with following pH 
values: 5, 6, 7. F2 was dissolved in MeOH, EtOH and in EtOH/H2O (80:20) mixture. The samples 
were divided into two separate series, called “dark” (naturally preserved in the absence of light.) and 
“oven” (subjected to accelerated aging in an oven at 40 °C). 
3.4.2. Dermo-Cosmetic Formulations 
In this study, F2 in different formulations has been subjected to accelerated aging in an oven at  
40 °C, and analyzed by HPLC with the aim to asses its content over time. The study was carried out on 
two different formulations, containing 0.3% of the active ingredient. The formulations tested are 
described following International Nomenclature of Cosmetic Ingredients (INCI) rules: (1) INCI:  
Aqua, Glycerin, Glyceryl stearate, Ceteareth-20, Ceteareth-12, Cetyl palmitate, Cetearyl alcohol, 
Dimethicone, Caprylic/capric triglyceride, Dicapryl carbonate, Symdiol 68T. From a technological 
point of view, it is an O/W formulation. (2) INCI: Nomcort T.I.O., Nomcort HK-G, Kester Wax 
Molecules 2012, 17 13285 
 
K82D, Covabead LH170, denaturated EtOH. From a technological point of view it is an  
anhydrous formulation. 
3.4.3. HPLC Methods 
HPLC analysis was performed using an Agilent 1100 Series HPLC System equipped with a 
G1315A DAD and with an Hydro RP18 Sinergi 80A column (4.6 × 150 mm, 4 μm) from 
Phenomenex. The mobile phase consisted of water (0.01 M H3PO4) (solvent A) and acetonitrile 
(0.01 M H3PO4) (solvent B). 
(1) Phloridzin: in this study, phloridzin in solution has been subjected to accelerated aging in an 
oven at 40 °C, and analyzed by HPLC with the aim to asses the content of this active ingredient over 
time. The determination is carried out under isocratic condition, A (73%)/B (25%) Separation was 
monitorated with absorbance detection at 284 ± 8 nm. The flow rate was 1.0 ml/min, the injection 
volume was 2 μL and all separation was performed at 27 °C. 
(2) F2: in this study, F2 in solution and in formulations has been subjected to accelerated aging in 
an oven at 40 °C, and analyzed by HPLC with the aim to asses the content of this active ingredient 
over time. The determination is carried out under isocratic condition, A (40%)/B (60%). Separation 
was monitorated with absorbance detection at 284 ± 8 nm. The flow rate was 1.2 mL/min, the injection 
volume was 5 μl and all separation was performed at 27 °C. 
3.4.4. Statistical Evaluations 
Relative standard deviations and statistical significance (Student’s t test; p ≤ 0.05) were given 
where appropriate for all data collected. One-way ANOVA and LSD post hoc Tukey’s honest 
significant difference test were used for comparing the bioactive effects of different samples. All 
computations were made using the statistical software STATISTICA 6.0 (StatSoft Italia srl, Vigonza 
(PD), Italy). 
3.5. Antifungal Activity 
3.5.1. Microorganisms 
Phloridzin and its derivative F2 were tested on fungal species, pathogenic for animals and humans, 
such as some dermatophytes. The dermatophytes used were Nannizzia cajetani Ajello, CBS 495.70 
strain; Epidermophyton floccosum (Hartz) Langeron and Milochevitch, CBS 358.93 strain; 
Trichophyton violaceum Malmsten, CBS 459.61 strain; Trichophyton tonsurans Malmsten, CBS 
483.76 strain, Trichophyton mentagrophytes (Robin) Blanchard, CBS 160.66 strain,Microsporum 
canis Bodin CBS 4727 strain, Nannizzia gypsea (Bodin) Guiart et Grigoraki CBS 286.63 purchased 
from Centraal Bureau voor Schimmelcultures (CBS), Baarn, The Netherlands; Trichophyton rubrum 
(Castellani) Sabouraud IHME 4321 strain, Microsporum gypseum (Bodin) Guiart and Grigorakis 
IHME 3999 strain obtained from the Institute of Hygiene and Epidemiology-Mycology (IHME, 
Brussels, Belgium). The cultures were maintained in the laboratory as agar slants on a suitable culture 
medium, that is, on Sabouraud dextrose agar (SDA; Difco), for the dermatophytes. 
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3.5.2. Evaluation of Antifungal Activity 
To evaluate antifungal activity, cultures of each fungus were obtained by transplanting mycelium 
disks, 10 mm in diameter, from a single culture in stationary phase. These were incubated at 26 ± 1 °C 
on the medium suitable for each organism (SDA), on thin sterile sheets of cellophane, until the 
logarithmic phase of growth was reached. Then the fungi were transferred to Petri dishes containing 
the medium supplemented with the compound to be tested. Each compound was dissolved into 
dimethyl sulfoxide (DMSO), and a proper dilution was aseptically added to the medium at 45 °C to 
obtain a final concentration of 20, or 100 g mL−1. The DMSO concentration in the final solution was 
adjusted to 0.1%. Controls were set up with equivalent quantities (0.1%) of DMSO. The growth rate 
was determined by measuring daily colony diameter for 7 days after the transport of the fungus onto 
dishes containing the substance to be tested. At this time the percentage growth inhibition in 
comparison with the control was evaluated for each fungus. Three replicates were used for each 
concentration. The percentage of growth inhibition was expressed as the mean of values obtained in 
three independent experiments.  
The relative inhibition rate of the circle mycelium compared to blank assay was calculated via the 
following equation: 
Relative inhibition rate (%) = [(dex − dex′)/dex] × 100% 
where dex is the extended diameter of the circle mycelium during the blank assay; and dex' is the 
extended diameter of the circle mycelium during testing. 
4. Conclusions 
In conclusion, phloridzin and its derivative F2 exhibited similar antioxidant capacity in PCL 
analysis and an ORAC test. This demonstrates that the structural modification does not decrease 
efficacy toward oxidative species. The importance of the structural modification is demonstrated by 
the formulation study, where the modification of the sugar hydroxyl groups increases lipophilicity, but 
keeps free the active phenol moieties, and allows one to obtain a molecule that is still active but much 
more stable in dermo-cosmetic formulae. On the other hand phloridzin itself is difficult to use because 
of the quick appearance of a brown coloration which is an undesirable behaviour for applications. In 
order to exploit functional effects, beside antioxidant ones, that could be useful for health applications, 
the antifungal activity of phloridzin and its derivative F2 have been explored but they both show a low 
inhibition; only F2 on Microsporum canis reached a remarkable value but significative enough to 
suggest a use as an antifungal. Interestingly, in all the other cases the substance showed an  
hormone-like effect with a fungal growth higher than that of the controls. This behavior certainly 
deserves further investigation. In order to explore the potential of phloridzin and its new derivative in 
the dermo-cosmetic and medicinal fields other studies are planned to investigate the antioxidant,  
anti-inflammatory, antiproliferative (on K562 and IB3-1 cells) activities. 
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